[Top][All Lists]

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Bio Tech news. Technology lilfesaving watch Mon.

From: Kasey Maryanne
Subject: Bio Tech news. Technology lilfesaving watch Mon.
Date: Mon, 25 Jul 2005 07:32:38 -0500


Pacific Sunset Investments Inc.
SHORT-TERM:  $1.00

How many times have you heard about this????
adverse drug reactions accounted for more than 2.2 million serious cases and
over 100,000 deaths,


A study published in the Journal of the American Medical Association
reported that adverse drug reactions accounted for more than 2.2 million
serious cases and over 100,000 deaths, making adverse drug reactions (ADRs)
one of the leading causes of hospitalization and death in the United States.

Breaking News for Pacific Sunset Investments

Pacific Sunset Investments Completes Gen ID Acquisition
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--May 20, 2005--Pacific Sunset
Investments, Inc. ("Pacific Sunset") (OTC:PSiV announced that it has
completed its acquisition of Gen-ID Lab Services, LLC, a California limited
liability corporation specializing in Single Nucleotide Polymorphism
analysis data. In addition, the board of directors of Pacific Sunset has
appointed Douglas Freedman to its board of directors with experience in
marketing. Additionally, the company has appointed Dr. Steve N. Slilaty,
Ph.D., to head an Advisory Board to assist the company with reviewing new
alternatives in the "SNP" field of technology.

Gen ID will provide "SNP" (Single Nucleotide Polymorphism) analysis data.
The results of SNP analysis provide physicians with a more enlightened
choice of drugs and they will also be able to predict the effectiveness of
the drugs for individual patients. The use of an SNP test to help treat
childhood leukemia is currently being used by doctors and hospitals in the
United States.

Dr. Steve Slilaty is President and Chief Scientific Officer of Advanomics
Corporation, a leading-edge biotechnology company focusing on the
identification of disease related molecular targets using advanced
transriptomics technologies, which he recently developed. Dr. Slilaty also
is an Adjunct Professor at the Universite du Quebec in the department of
Microbiology and Biotechnology. Dr. Slilaty has founded three biotechnology
companies, Advanomics Corporation, Quantum Biotechnologies Inc. (now known
as Qbiogene Inc.) and Geneomics One Corporation. In addition, Dr. Slilaty is
one of the pioneers of Gene Therapy, having developed the first Gene
Transfer system in 1983.

(This is a partial clip of the news.  We suggest you go read the whole
release.  Our opinion is, this is important technology.  Go to yahoo or any
financial site and read the news)

adverse drug reactions accounted for more than 2.2 million serious cases and
over 100,000 deaths,  Doesn't this say it all?

 A company to watch!

PUT Pacific Sunset Investments Inc. PSiV

Information within this email contains "forwardlooking statements" within
the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of
the Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact and may be "forward
looking statements". "Forward looking statements" are based on
expectations, estimates and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through the use
of words such as "projects", "foresee", "expects", "will", "anticipates",
"estimates", "believes", "understands" or that by statements indicating
certain actions "may", "could", or "might" occur. Risk factors include
general economic and business conditions, the ability to acquire and develop
specific projects, the ability to fund operations and changes in consumer
and business consumption habits and other factors overwhich the company has
little or no control. The publisher of this newsletter does not represent
that the information contained in this message states all material facts or
does not omit a material fact necessary to make the statements therein not
misleading. All information provided within this email pertaining to
investing, ST0CKs, securities must be understood as information provided and
not investment advice. The publisher of this newsletter advises all readers
and subscribers to seek advice from a registered professional securities
representative before deciding to trade in ST0CKs featured within this
email. None of the material within this report shall be construed as any
kind of investment advice or solicitation. Many of these companies are on
the verge of bankruptcy. You can lose all your money by investing in this
ST0CK. We urge you to read the company's SEC filings now, before you invest.
The publisher of this newsletter is not a registered invstment advisor.
Subscribers should not view information herein as legal, tax, accounting or
investment advice. In compliance with the SecuritiesAct of 1933, Section
17(b), The publisher of this newsletter is contracted to receive six hundred
thousand free trading shares from a third party, not an officer, director or
affiliate shareholder for the circulation of this report. Be aware of an
inherent conflict of interest resulting from such compensation due to the
fact that this is a paid advertisement and is not without bias. The party
that paid us has a position in the ST0CK they will sell at anytime without
notice. This could have a negative impact on the price of the ST0CK, causing
you to lose money. All factual information in this report was gathered from
public sources, including but not limited to SEC filings, Company Websites
and Company Press Releases. The publisher of this newsletter believes this
information to be reliable but can make no guarantee as to its accuracy or
completeness. Use of the material within this email constitutes your
acceptance of these terms.

yards meters from where a Unity Day event 
was set to be held a few hours 
laterUnity Day was established by the US military 
as an incentive to
insurgents and Baathists to stop their attacks The 
regional grouping Ecowas said Mr Faure's promise to 
hold elections within 60 v days was not enough 
The sanctions include suspension from Ecowas the recall v 
of ambassadors from Togo 
a travel ban on the Togolese leadership and 
an arms embargo The African Union has also 
condemned Mr Gnassingbe's refusal to leave was speaking v 
after meeting a highlevel Togolese delegation in Nigeria 
Rival rallies Under the original constitution which was 
amended to legitimise Mr Faure's installation the parliamentary 
speaker should hold the presidency pending the election 
The opposition wants the new leader to step 
down immediately In Togo 

itself rival demonstrations by critics and supporters of 
the new leader passed off peacefully on Saturday 
At least 10000 opposition demonstrators marched through the 
streets of the capital 
Lome Many carried placards denouncing the new leader 
as a "thief" who had stolen power Thousands 
of ruling party supporters gathered separately at the 
president's residence moving I'll never forget this" Mr 
Bush said at a news conference in the 
Baan Nam Khem village just north of the v
resort of Phuket Click here for details of 
aid donations so farHe was speaking after a v v 
little girl whose mother was killed by the v v 
tsunami gave him a 

reply via email to

[Prev in Thread] Current Thread [Next in Thread]